Breaking News

Emmes Awarded Multi-Task IDIQ Contract

Will support the National Institute of Drug Abuse’s clinical trials network.

Author Image

By: Charlie Sternberg

Associate Editor

Emmes, part of Emmes Group, a specialty tech-enabled global contract research organization (CRO), has been selected by the National Institutes of Health’s (NIH) NIDA (National Institute of Drug Abuse) to support their Clinical Trials Network (CTN) for a multi-task, IDIQ contract.   The management of NIDA Clinical Trial Network is supported by the Data and Statistical Coordinating Center (DSC) and the Clinical Coordinating Center (CCC), both done by Emmes. This new contract was awarded to Emmes...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters